Jeffrey G Clark1, Arvind I Srinath, Ada O Youk, Margaret A Kirshner, F Nicole McCarthy, David J Keljo, Athos Bousvaros, David R DeMaso, Eva M Szigethy. 1. *Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University, Cleveland, OH †Division of Pediatric Gastroenterology, Children's Hospital of Pittsburgh ‡Graduate School of Public Health §Division of Rheumatology and Clinical Immunology, University of Pittsburgh ||Medical Coping Clinic, Children's Hospital of Pittsburgh, Pittsburgh, PA ¶Department of Gastroenterology #Department of Psychiatry, Boston Children's Hospital, Boston, MA **Department of Psychiatry, Children's Hospital of Pittsburgh, Pittsburgh, PA.
Abstract
OBJECTIVE: The aim of the study was to determine whether infliximab use and other potential predictors are associated with decreased prevalence and severity of depression in pediatric patients with Crohn disease (CD). METHODS:A total of 550 (n = 550) youth ages 9 to 17 years with biopsy-confirmed CD were consecutively recruited as part of a multicenter randomized controlled trial. Out of the 550, 499 patients met study criteria and were included in the analysis. At recruitment, each subject and a parent completed the Children's Depression Inventory (CDI). A child or parent CDI score ≥ 12 was used to denote clinically significant depressive symptoms (CSDS). Child and parent CDI scores were summed to form total CDI (CDIT). Infliximab use, demographic information, steroid use, laboratory values, and Pediatric Crohn's Disease Activity Index (PCDAI) were collected as the potential predictors of depression. Univariate regression models were constructed to determine the relations among predictors, CSDS, and CDIT. Stepwise multivariate regression models were constructed to predict the relation between infliximab use and depression while controlling for other predictors of depression. RESULTS:Infliximab use was not associated with a decreased proportion of CSDS and CDIT after adjusting for multiple comparisons. CSDS and CDIT were positively associated with PCDAI, erythrocyte sedimentation rate, and steroid dose (P < 0.01) and negatively associated with socioeconomic status (SES) (P < 0.001). In multivariate models, PCDAI and SES were the strongest predictors of depression. CONCLUSIONS: Disease activity and SES are significant predictors of depression in youth with Crohn disease.
RCT Entities:
OBJECTIVE: The aim of the study was to determine whether infliximab use and other potential predictors are associated with decreased prevalence and severity of depression in pediatric patients with Crohn disease (CD). METHODS: A total of 550 (n = 550) youth ages 9 to 17 years with biopsy-confirmed CD were consecutively recruited as part of a multicenter randomized controlled trial. Out of the 550, 499 patients met study criteria and were included in the analysis. At recruitment, each subject and a parent completed the Children's Depression Inventory (CDI). A child or parent CDI score ≥ 12 was used to denote clinically significant depressive symptoms (CSDS). Child and parent CDI scores were summed to form total CDI (CDIT). Infliximab use, demographic information, steroid use, laboratory values, and Pediatric Crohn's Disease Activity Index (PCDAI) were collected as the potential predictors of depression. Univariate regression models were constructed to determine the relations among predictors, CSDS, and CDIT. Stepwise multivariate regression models were constructed to predict the relation between infliximab use and depression while controlling for other predictors of depression. RESULTS:Infliximab use was not associated with a decreased proportion of CSDS and CDIT after adjusting for multiple comparisons. CSDS and CDIT were positively associated with PCDAI, erythrocyte sedimentation rate, and steroid dose (P < 0.01) and negatively associated with socioeconomic status (SES) (P < 0.001). In multivariate models, PCDAI and SES were the strongest predictors of depression. CONCLUSIONS: Disease activity and SES are significant predictors of depression in youth with Crohn disease.
Authors: Dan Turner; Anne M Griffiths; Thomas D Walters; Tong Seah; James Markowitz; Marian Pfefferkorn; David Keljo; Anthony Otley; Neal S Leleiko; David Mack; Jeffrey Hyams; Arie Levine Journal: Am J Gastroenterol Date: 2010-04-06 Impact factor: 10.864
Authors: Alan Menter; Matthias Augustin; James Signorovitch; Andrew P Yu; Eric Q Wu; Shiraz R Gupta; Yanjun Bao; Parvez Mulani Journal: J Am Acad Dermatol Date: 2010-03-09 Impact factor: 11.527
Authors: Rachel D Thompson; Anna Craig; Emily A Crawford; Diane Fairclough; Joseph Gonzalez-Heydrich; Athos Bousvaros; Robert B Noll; David R DeMaso; Eva Szigethy Journal: J Clin Psychol Med Settings Date: 2012-09
Authors: Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt Journal: Biol Psychiatry Date: 2009-12-16 Impact factor: 13.382
Authors: Laura M Mackner; Rachel Neff Greenley; Eva Szigethy; Michele Herzer; Kate Deer; Kevin A Hommel Journal: J Pediatr Gastroenterol Nutr Date: 2013-04 Impact factor: 2.839
Authors: Christian Mittermaier; Clemens Dejaco; Thomas Waldhoer; Anna Oefferlbauer-Ernst; Wolfgang Miehsler; Markus Beier; Wolfgang Tillinger; Alfred Gangl; Gabriele Moser Journal: Psychosom Med Date: 2004 Jan-Feb Impact factor: 4.312
Authors: Jason C O'Connor; Caroline André; Yunxia Wang; Marcus A Lawson; Sandra S Szegedi; Jacques Lestage; Nathalie Castanon; Keith W Kelley; Robert Dantzer Journal: J Neurosci Date: 2009-04-01 Impact factor: 6.167
Authors: Arie Levine; Anne Griffiths; James Markowitz; David C Wilson; Dan Turner; Richard K Russell; John Fell; Frank M Ruemmele; Thomas Walters; Mary Sherlock; Marla Dubinsky; Jeffrey S Hyams Journal: Inflamm Bowel Dis Date: 2010-11-08 Impact factor: 5.325
Authors: Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens Journal: J Pediatr Psychol Date: 2018-10-01
Authors: Clayton S Edwards; Caroline M Roberts; Marissa N Baudino; Nathan L Basile; Kaitlyn L Gamwell; Noel J Jacobs; Jeanne Tung; John E Grunow; Larry L Mullins; John M Chaney Journal: J Clin Psychol Med Settings Date: 2022-06-06
Authors: Gertrude van den Brink; Luuk Stapersma; Hanan El Marroun; Jens Henrichs; Eva M Szigethy; Elisabeth Mwj Utens; Johanna C Escher Journal: BMJ Open Gastroenterol Date: 2016-03-02
Authors: Jonathan Blackwell; Christopher Alexakis; Sonia Saxena; Hanna Creese; Alex Bottle; Irene Petersen; Matthew Hotopf; Richard C G Pollok Journal: BMJ Open Gastroenterol Date: 2021-05